Detection of curative effects of tamoxifen in auxiliary treatment of breast cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HAINAN ZHUJIAN CELL MOLECULE GENETICS INSPECTION CENT
- Publication Date
- 2010-12-29
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The present invention relates to the fields of molecular biology and medicine. More specifically, the present invention relates to a kit for detecting the curative effect of individual tamoxifen adjuvant treatment of breast cancer, by detecting the polymorphism of the CYP2D6 gene at the site targeted by tamoxifen sites to assess the efficacy of individual adjuvant tamoxifen therapy in breast cancer. Background technique
[0002] Breast cancer is a disease in which ductal epithelial cells of the mammary gland lose their normal characteristics and proliferate abnormally under the action of various internal and external carcinogenic factors, so that they exceed the limit of self-repair and become cancerous. The main clinical manifestation is breast lumps. Breast cancer is one of the most common malignant tumors in women. It has the characteristics of high incidence, aggressiveness, slow progression and long natural survival period.
[0003] Breast cancer...